tiprankstipranks
Trending News
More News >
Pharmacorp Rx Inc. (TSE:PCRX)
:PCRX
Canadian Market

Pharmacorp Rx Inc. (PCRX) Income Statement

Compare
2 Followers

Pharmacorp Rx Inc. Income Statement

Last quarter (Q3 2024), Pharmacorp Rx Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Pharmacorp Rx Inc.'s net income was $-975.86K. See Pharmacorp Rx Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22
Total Revenue
$ ―$ ―
Gross Profit
$ ―$ ―
Operating Expenses
$ ―$ ―
Depreciation and Amortization
$ ―$ ―
EBITDA
$ -470.43K$ -517.09K
Operating Income
$ -577.96K$ -563.18K
Other Income/Expenses
$ ―$ ―
Pretax Income
$ ―$ ―
Net Income
$ -470.43K$ -517.09K
Per Share Metrics
Basic EPS
$ ―$ ―
Diluted EPS
$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Pharmacorp Rx Inc. Earnings and Revenue History